Plus: health officials continue to track new ‘variants of concern,’ and the head of the state Communicable Disease Service says not everyone is taking appropriate precautions a year-and-a-half into the pandemic.
By Matt Skoufalos | September 1, 2021
Another 1,841 New Jersey residents have tested positive for novel coronavirus (COVID-19), bringing the statewide total to 953,616 cases confirmed via polymerase chain reaction (PCR) testing, Governor Phil Murphy reported Wednesday.
New Jersey is also reporting 585 new COVID-probable cases based on antigen tests, bringing the statewide total to 140,633 positive antigen tests.
Antigen tests have a faster turnaround time than PCR tests—sometime within 15 to 30 minutes—but are less reliable at detecting active infection of the virus, and more capable of reporting false positives.
Sadly, 20 more residents have perished from complications related to the virus, bringing the statewide, confirmed death toll to 24,171 lives lost during the pandemic.
In addition to those lab-confirmed fatalities, the state has acknowledged another 2,722 probable COVID-19-related deaths—two more than previously reported.
Since March 2020, 1,015 of every 100,000 New Jersey residents have been hospitalized with COVID-19, and 275 of every 100,000 have died from COVID-19-related complications.
More than 15.075 million polymerase chain reaction (PCR) tests for COVID-19 have been performed statewide, with a 10.826-percent positivity rate per 100,000 residents.
Rate of transmission (Rt) at 1.08, spot positivity highest in South Jersey
The statewide average of COVID-19 spot positivity testing based on PCR test results stood at 6.98 percent August 28; in South Jersey, it was highest, at 8.84 percent.
Rt, the variable that describes the seven-day, rolling-average, statewide rate of transmission of new COVID-19 cases, hit 1.08 on September 1.
Any Rt figure greater than 1.0 means that each new COVID-19 patient is infecting fewer than one other person, on average, and the spread of the virus is decreasing.
Since its mid-April-2020 COVID-19 spike, the highest reported RT in New Jersey was 1.48, recorded August 1, 2020. Prior to artificially low, adjusted reports of 0.34 in the first week of May, the lowest in the past year was 0.62, recorded June 9, 2020. On May 21, 2021, it reached a new low, of 0.59.
Hospitalizations up 22 percent in two weeks
Throughout New Jersey, 1,065 people currently are hospitalized with a suspected (49) or confirmed (1,016) case of COVID-19, Murphy said.
Among those hospitalized patients, 211 are in intensive or critical care, and 108 of the ICU and critical-care patients (51 percent) are on ventilators.
In New Jersey’s 71 critical care hospitals, 167 patients were hospitalized with COVID-19 yesterday, while 151 others were discharged.
Despite seeing “some leveling-off of cases and hospitalizations,” New Jersey has seen a 22-percent increase in people hospitalized by COVID-19 although over the last two weeks, said New Jersey Health Commissioner Judy Persichilli.
However, “when we compare ourselves to other states, we’re in much better shape,” Persichilli said, noting that along with its neighbors in Connecticut, Massachusetts, and New York, New Jersey is “clustered at the lower end of [newly reported COVID-19]. cases.”
Across the state, long-term care (LTC) centers have reported 1,645 cumulative outbreaks of COVID-19, and 140 are dealing with an active outbreak. LTCs account for 55,984 infected patients and staff in New Jersey, or 5.8 percent of total cases.
That includes 33,313 residents and 22,671 staffers sickened by the virus, as well as 8,471 lab-confirmed resident and staff deaths (34 percent of the statewide confirmed total), with facilities self-reporting 144 staff deaths.
Of 648 veterans residing in three state-run homes, 456 residents have tested positive for COVID-19, and 156 have died from complications related to the virus. Three hundred veterans have recovered from the virus. No resident is currently COVID-19-positive; three staffers presently are.
The facilities at Menlo Park, Paramus, and Vineland are staffed by 1,370 workers, one of whom is presently COVID-19-positive. The facilities have sustained two staff deaths related to the virus.
At state-run psychiatric facilities, 372 of 1,133 patients and 1,080 staff members have tested positive for COVID-19. Fourteen patients and eight staffers have died from complications related to the virus.
MISC cases and schools
To date, 130 New Jersey children aged 1 to 18 have been diagnosed with pediatric multisystem inflammatory syndrome (MISC). Four of those cases were reported in Camden County, tied with Cumberland and Monmouth Counties for third-least in the state.
All those pediatric patients have tested positive for an active COVID-19 infection or the presence of COVID-19 antibodies, indicating exposure to the virus. No deaths have been associated with this syndrome in New Jersey, although several children have been hospitalized during their treatment for the illness.
Since August 1, 2020, 281 COVID-19 outbreaks encompassing 1,263 individual cases have been traced to schools in all 21 New Jersey counties. In Camden County, 18 outbreaks have been linked to 78 cases, sixth-most in the state.
Vaccination update: NJ approaches 6M fully vaccinated people, exceeds 11M doses administered
Across New Jersey, 11.135 million COVID-19 inoculations have been administered.
Throughout New Jersey, 5.423 million people have been fully vaccinated in-state, having received either a one-shot formulation from Johnson and Johnson or both doses of the two-shot Pfizer or Moderna vaccines.
In Camden County, 590,139 doses have been administered; seventh-most in the state.
An estimated 404,540 vaccine doses have been administered to New Jersey residents outside of the state, of which 174,999 residents are estimated to have been fully vaccinated.
The first vaccines in the state were administered December 15, 2020; by February 8—55 days later—New Jersey had immunized its millionth resident. Twenty days thereafter, that count hit 2 million, and 3 million within two more weeks.
On March 29, New Jersey crossed the 4-million-dose threshold, and the state cleared 5 million doses over the weekend of April 10, 2021. Eight days after that, New Jersey hit the 6-million-dose mark. By May 3, 2021, the state had cleared 7 million doses administered, and two weeks later, it had surpassed 8 million doses.
As of June 2, 2021, the state had cleared 9 million administered doses and 4 million fully vaccinated New Jerseyans, and on June 18, hit 4.7 million vaccinated individuals, its target goal for 70 percent of the adult population of the state.
By mid-July, that number had increased to 5.019 people fully vaccinated at New Jersey vaccination sites. By the end of August 2021, the state had exceeded 11 million doses administered and was approaching 6 million fully vaccinated residents.
Boosters versus third doses
As New Jersey prepares its infrastructure to help dispense additional doses of the COVID-19 vaccine for those who need it, Murphy offered some comparison on the differences between booster doses—those taken by people with healthy immune systems—and third doses, which are intended as the final installment of a series of shots for those with compromised immunity.
The governor said health officials are awaiting guidance on whether those requiring a booster should get it eight or six months after having completed their one- or two-shot regimens.
$267M to support K-12 school screening and testing programs
In keeping with the statewide mandate for all school staff and contractors to be fully vaccinated by October 15 or face routine COVID-19 testing, the governor announced some $267 million in additional funds would be available to support said testing.
School districts may use state-contracted vendors for end-to-end testing services, or can ask for funding to support their own in-house testing programs that may already be in place, Murphy said.
“We don’t know how far, at this point, the money will actually go as we provide these tests at no cost,” the governor said, promising to “find federal money to make up the balance” of any shortfall.
Persichilli noted that, in order to qualify for the funding, “districts must develop a testing plan that meets the state guidelines,” and which is a component of a layered COVID-19 prevention approach that includes common mitigation strategies like masking, hand-washing, physical distancing, and staying home when sick or symptomatic.
Those who are vaccinated fully do not need to participate in the routine testing, she added. That includes 44 percent of New Jersey children aged 12 to 17; the commissioner also said that 55 percent of people in that same age cohort have received at least one vaccine dose.
New variants? NJ on the rebound?
As health officials have seen the impact of the B.1.617.2 “Delta” variant play out across a 12-week period internationally, Persichilli said it’s uncertain whether Americans will enjoy the same relief as Delta has abated overseas.
The commissioner noted that the World Health Organization (WHO) is currently monitoring a number of other variants of concern, including C.37 “Lambda,” which originated in Peru in December 2020, and B.1.621 “Mu,” which originated in Colombia in January 2021.
She did not confirm whether any such cases have been identified yet in New Jersey.
Finally, Dr. Ed Lifshitz, who heads up the state Communicable Disease Service, reported that although “we’re in a whole lot better situation than we were last year,” in terms of battling the pandemic, “also, unfortunately, we’re in a whole lot worse situation than a lot of people think we’re in.
“I almost see two different states,” Lifshitz said: people who are adhering to COVID-19 precautions, and those who are “acting as if COVID has been completely defeated,” and contributing to the continued spread of the virus.
Lifshitz also said that he would not be surprised to see an uptick in cases as the school year resumes, explicitly adding, “If we were not going into a school year, we would be seeing drop-offs.”
Please support NJ Pen with a subscription. Get e-mails, follow us on Facebook, Twitter, and Instagram, or try our Direct Dispatch text alerts.